David Mountcastle - Apr 1, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in-fact __________________________
Stock symbol
PRVA
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 08:53 AM
Previous filing
Dec 20, 2022
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Award $0 +48.8K +151.32% $0.00 81.1K Apr 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Award $0 +64.9K $0.00 64.9K Apr 1, 2022 Common Stock 64.9K $26.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 1, 2022, the reporting person received 48,833 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.
F2 On April 1, 2022, the reporting person received 64,882 stock options under the Issuer's 2021 Omnibus Incentive Plan. The stock options will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.